(Q48404270)

11 February 2018

title

Ethical and design issues of phase I clinical trials in cancer patients (English)

1 reference

11 February 2018

main subject

phase I clinical trial

0 references

1 reference

Hans W Grünwald

1

1 reference

11 February 2018

publication date

1 March 2007

1 reference

11 February 2018

published in

Cancer Investigation

1 reference

11 February 2018

volume

25

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

124-126

1 reference

11 February 2018

Evidence based medicine: what it is and what it isn't

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Research ethics committees and paternalism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Design and analysis of phase I clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

The continual reassessment method in cancer phase I clinical trials: a simulation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Using toxicity grades in the design and analysis of cancer phase i clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Phase I trials in cancer treatment. The maximum tolerated dose: a barbarian guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

A comparison of two phase I trial designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Some practical improvements in the continual reassessment method for phase I studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Cancer phase I clinical trials: efficient dose escalation with overdose control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Phase I trials in cancer patients: participants' perceptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Ethical issues in the development of new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Phase I cancer trials. A collusion of misunderstanding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Must patients with advanced cancer choose between a Phase I trial and hospice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

Descriptions of benefits and risks in consent forms for phase 1 oncology trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701225331

10.1080/07357900701225331

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

release_caax5gp7jvefzfvxq6ffestfue

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/caax5gp7jvefzfvxq6ffestfue

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 February 2018